Javascript must be enabled to continue!
Effect of Dosage on Severity of Dysphagia in a Toxicological Rat Model of Parkinson's Disease
View through CrossRef
Parkinson’s Disease (PD) is a prevalent and devastating neurodegenerative disorder that causes progressively worsening motor symptoms affecting locomotor and oropharyngeal function. There is limited research in animal models on swallowing dysfunction in PD. To examine how neurodegeneration in PD produces progressive impairment in the oropharyngeal and locomotor processes, rotenone, a type II mitochondrial inhibitor, was injected into Lewis rat models to reproduce a parkinsonian phenotype. We hypothesized that the animal models injected with the rotenone will exhibit both oropharyngeal dysfunction and locomotor deficiency with an increased deficit that correlates with prolonged treatment. We utilized 18 rats receiving either 2.75 mg/kg of rotenone or vehicle intraperitoneal injections. Animals received daily injections for 17 or 8 days. At the end of the injections in each group brains were perfused and immunostained for striatal tyrosine hydroxylase (TH). Videofluoroscopic recording was taken of these rats and average chew cycle length and total chewing time data were collected from days 0, 1, 4, 7 and 16 of those recordings. From these recordings the number of chewing cycles prior to a swallow were counted, total time chewing was measured, and average duration of a chewing cycle was calculated. The number of rears by a rat in a glass cylinder over 4 minutes was counted on the same days to assess locomotor behavior. Total chewing time and average chew cycle duration increased in rotenone treated rats from day 0 to day 4, but the difference disappeared from day 7 onwards. However, rearing behavior was consistently reduced in rotenone treated rats for all 16 days. Tyrosine hydroxylase staining intensity in the striatum decreased consistently over the course of the injections. These results suggest that rotenone treated rats have temporary/short term deficiency in chewing function. The restoration of function after day 4 may indicate a learned behavior to compensate for this dysfunction in chewing, or point to a different neurological impairment than that seen in locomotor behavior. Further research needs to be undertaken to address this phenomenon.
Rowan University Libraries
Title: Effect of Dosage on Severity of Dysphagia in a Toxicological Rat Model of Parkinson's Disease
Description:
Parkinson’s Disease (PD) is a prevalent and devastating neurodegenerative disorder that causes progressively worsening motor symptoms affecting locomotor and oropharyngeal function.
There is limited research in animal models on swallowing dysfunction in PD.
To examine how neurodegeneration in PD produces progressive impairment in the oropharyngeal and locomotor processes, rotenone, a type II mitochondrial inhibitor, was injected into Lewis rat models to reproduce a parkinsonian phenotype.
We hypothesized that the animal models injected with the rotenone will exhibit both oropharyngeal dysfunction and locomotor deficiency with an increased deficit that correlates with prolonged treatment.
We utilized 18 rats receiving either 2.
75 mg/kg of rotenone or vehicle intraperitoneal injections.
Animals received daily injections for 17 or 8 days.
At the end of the injections in each group brains were perfused and immunostained for striatal tyrosine hydroxylase (TH).
Videofluoroscopic recording was taken of these rats and average chew cycle length and total chewing time data were collected from days 0, 1, 4, 7 and 16 of those recordings.
From these recordings the number of chewing cycles prior to a swallow were counted, total time chewing was measured, and average duration of a chewing cycle was calculated.
The number of rears by a rat in a glass cylinder over 4 minutes was counted on the same days to assess locomotor behavior.
Total chewing time and average chew cycle duration increased in rotenone treated rats from day 0 to day 4, but the difference disappeared from day 7 onwards.
However, rearing behavior was consistently reduced in rotenone treated rats for all 16 days.
Tyrosine hydroxylase staining intensity in the striatum decreased consistently over the course of the injections.
These results suggest that rotenone treated rats have temporary/short term deficiency in chewing function.
The restoration of function after day 4 may indicate a learned behavior to compensate for this dysfunction in chewing, or point to a different neurological impairment than that seen in locomotor behavior.
Further research needs to be undertaken to address this phenomenon.
Related Results
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
1.Effect of chronic haloperidol treatment on D‐2 receptors labelled by (3H)‐spiperone in homogenates of rat corpus striatum. A. L. Gundlach, D. J. de Vries and P. M. Beart2.The eff...
Incidence and Risk Factors of postoperative Dysphagia following Cervical Spine Surgery
Incidence and Risk Factors of postoperative Dysphagia following Cervical Spine Surgery
Abstract
Background. Dysphagia is a known complication of anterior cervical spine surgery and may be prolonged or occasionally serious. However, the association between pos...
OROPHARYNGEAL DYSPHAGIA: AN ASSOCIATION BETWEEN DYSPHAGIA LEVEL, SYMPTOMS AND COMORBIDITY
OROPHARYNGEAL DYSPHAGIA: AN ASSOCIATION BETWEEN DYSPHAGIA LEVEL, SYMPTOMS AND COMORBIDITY
Objective: Associate levels of dysphagia according to the patient health condition. Methods: Retrospective study analyzing 149 medical records of patients who underwent Fiberoptic ...
The Prevalence of Dysphagia in Parkinson’s Disease: A Systematic Review and Meta-Analysis
The Prevalence of Dysphagia in Parkinson’s Disease: A Systematic Review and Meta-Analysis
Background: There is still disagreement about the prevalence and incidence of dysphagia in Parkinson’s Disease (PD). Since the prevalence of dysphagia has been reported very differ...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
14th Annual Meeting, December 1980, Canberra1. Effect of dexamethasone on pineal β‐adrenoceptors. C. A. Maxwell, A. Foldes, N. T. Hinks and R. M. Hoskinson2. A clinicopathological ...
A Qualitative Study Exploring Patient Global Impression of Disease Severity in Early Stages of Parkinson’s Disease.
A Qualitative Study Exploring Patient Global Impression of Disease Severity in Early Stages of Parkinson’s Disease.
Abstract
Introduction
Although Parkinson’s Disease is the second most common neurodegenerative disease, the lived experience of individuals with early-stage Parkinson’s has...
Dysphagia Care and Management in Rehabilitation: A National Survey
Dysphagia Care and Management in Rehabilitation: A National Survey
Dysphagia care and management may differ between countries and healthcare settings. This study aims to describe the management and care of dysphagia in rehabilitation centres and h...
A multicenter cross-sectional survey of the knowledge, attitude, and behaviour of nurses regarding dysphagia after anterior cervical spine surgery: a prospective multicentre study
A multicenter cross-sectional survey of the knowledge, attitude, and behaviour of nurses regarding dysphagia after anterior cervical spine surgery: a prospective multicentre study
Abstract
Background
The incidence of dysphagia after anterior cervical spine surgery is high, which directly affects the quality of life of patients...

